"We believe that India and the US are going to be future markets for us, because as the economy grows there will be more spend power…
In Conversation
"Oncology and cardiology are the two main pillars of Bayer and this needs to be also reflected here."
"The services we provide to our clients' cover a much broader spectrum than our competitors."
"The country has great quality of care, especially in the fields of cardiology, cardio-surgery, neuro-surgery, transplantology and replantation of limbs."
"The private market still has a great potential to grow, thus for us this sector has still a large growth potential in the already well developed…
"In my opinion, the "Made in Switzerland" brand is not really a huge benefit as it automatically gives you the trademark of being expensive."
"I have always said that Canada exports brains. We have great researchers, key opinion leaders (KOLs), and clinical practice expertise that we can bring out of…
"Brazil clearly continues to be the driver of growth for Latin America despite the political and economic challenges recently faced by the country."
"As in any pharmaceutical company, the right product portfolio is a key factor to successfully navigate in the market, but it needs to be supported by…
"I am very satisfied with how far we have come in Tunisia, and I was able to implement all changes and reforms in order to bring…
"I am very satisfied with how far we have come in Tunisia, and I was able to implement all changes and reforms in order to bring…
We aim to stimulate the biomedical industry and our main mission is to fast-track medical R&D and improve three different types of lives: lifespan, daily life,…
